REPORT ID 6980

EMEA (Europe, Middle East and Africa) Diabetes Injection Pens Market Report 2017

Publish Date
1-Nov-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Diabetes Injection Pens market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Injection Pens for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Diabetes Injection Pens market competition by top manufacturers/players, with Diabetes Injection Pens sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novo Nordisk A/S
    Eli Lilly and Company
    AstraZeneca plc
    Biocon Ltd.
    Sanofi S.A.
    Becton, Dickinson and Company
    Owen Mumford Ltd.
    Jiangsu Delfu Co., Ltd.
    Wockhardt Ltd.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    By Usage
        Reusable Pens
        Disposable Pens
    By Product
        Insulin Pens
        Pen Needles

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Diabetes Injection Pens for each application, including
    Hospital Pharmacy
    Retail Pharmacy
    Online Sales
    Diabetes Clinics/ Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Diabetes Injection Pens Market Report 2017
1 Diabetes Injection Pens Overview
    1.1 Product Overview and Scope of Diabetes Injection Pens
    1.2 Classification of Diabetes Injection Pens
        1.2.1 EMEA Diabetes Injection Pens Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Diabetes Injection Pens Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Reusable Pens
        1.2.4 Disposable Pens
    1.3 EMEA Diabetes Injection Pens Market by Application/End Users
        1.3.1 EMEA Diabetes Injection Pens Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Sales
        1.3.5 Diabetes Clinics/ Centers
    1.4 EMEA Diabetes Injection Pens Market by Region
        1.4.1 EMEA Diabetes Injection Pens Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Diabetes Injection Pens (2012-2022)
        1.5.1 EMEA Diabetes Injection Pens Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Diabetes Injection Pens Revenue and Growth Rate (2012-2022)

2 EMEA Diabetes Injection Pens Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Diabetes Injection Pens Market Competition by Players/Manufacturers
        2.1.1 EMEA Diabetes Injection Pens Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Diabetes Injection Pens Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Diabetes Injection Pens Sale Price by Players (2012-2017)
    2.2 EMEA Diabetes Injection Pens (Volume and Value) by Type/Product Category
        2.2.1 EMEA Diabetes Injection Pens Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Diabetes Injection Pens Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Diabetes Injection Pens Sale Price by Type (2012-2017)
    2.3 EMEA Diabetes Injection Pens (Volume) by Application
    2.4 EMEA Diabetes Injection Pens (Volume and Value) by Region
        2.4.1 EMEA Diabetes Injection Pens Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Diabetes Injection Pens Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Diabetes Injection Pens Sales Price by Region (2012-2017)

3 Europe Diabetes Injection Pens (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Diabetes Injection Pens Sales and Value (2012-2017)
        3.1.1 Europe Diabetes Injection Pens Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Diabetes Injection Pens Revenue and Growth Rate (2012-2017)
    3.2 Europe Diabetes Injection Pens Sales and Market Share by Type
    3.3 Europe Diabetes Injection Pens Sales and Market Share by Application
    3.4 Europe Diabetes Injection Pens Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Diabetes Injection Pens Sales Volume by Countries (2012-2017)
        3.4.2 Europe Diabetes Injection Pens Revenue by Countries (2012-2017)
        3.4.3 Germany Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        3.4.4 France Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        3.4.5 UK Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        3.4.6 Russia Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        3.4.7 Italy Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Diabetes Injection Pens Sales and Growth Rate (2012-2017)

4 Middle East Diabetes Injection Pens (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Diabetes Injection Pens Sales and Value (2012-2017)
        4.1.1 Middle East Diabetes Injection Pens Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Diabetes Injection Pens Revenue and Growth Rate (2012-2017)
    4.2 Middle East Diabetes Injection Pens Sales and Market Share by Type
    4.3 Middle East Diabetes Injection Pens Sales and Market Share by Application
    4.4 Middle East Diabetes Injection Pens Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Diabetes Injection Pens Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Diabetes Injection Pens Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        4.4.4 Israel Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        4.4.5 UAE Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        4.4.6 Iran Diabetes Injection Pens Sales and Growth Rate (2012-2017)

5 Africa Diabetes Injection Pens (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Diabetes Injection Pens Sales and Value (2012-2017)
        5.1.1 Africa Diabetes Injection Pens Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Diabetes Injection Pens Revenue and Growth Rate (2012-2017)
    5.2 Africa Diabetes Injection Pens Sales and Market Share by Type
    5.3 Africa Diabetes Injection Pens Sales and Market Share by Application
    5.4 Africa Diabetes Injection Pens Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Diabetes Injection Pens Sales Volume by Countries (2012-2017)
        5.4.2 Africa Diabetes Injection Pens Revenue by Countries (2012-2017)
        5.4.3 South Africa Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Diabetes Injection Pens Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Diabetes Injection Pens Sales and Growth Rate (2012-2017)

6 EMEA Diabetes Injection Pens Manufacturers/Players Profiles and Sales Data
    6.1 Novo Nordisk A/S
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Diabetes Injection Pens Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Novo Nordisk A/S Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Eli Lilly and Company
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Diabetes Injection Pens Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Eli Lilly and Company Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 AstraZeneca plc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Diabetes Injection Pens Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 AstraZeneca plc Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Biocon Ltd.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Diabetes Injection Pens Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Biocon Ltd. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi S.A.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Diabetes Injection Pens Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi S.A. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Becton, Dickinson and Company
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Diabetes Injection Pens Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Becton, Dickinson and Company Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Owen Mumford Ltd.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Diabetes Injection Pens Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Owen Mumford Ltd. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Jiangsu Delfu Co., Ltd.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Diabetes Injection Pens Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Jiangsu Delfu Co., Ltd. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Wockhardt Ltd.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Diabetes Injection Pens Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Wockhardt Ltd. Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Diabetes Injection Pens Manufacturing Cost Analysis
    7.1 Diabetes Injection Pens Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Diabetes Injection Pens

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Diabetes Injection Pens Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Diabetes Injection Pens Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Diabetes Injection Pens Market Forecast (2017-2022)
    11.1 EMEA Diabetes Injection Pens Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Diabetes Injection Pens Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Diabetes Injection Pens Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Diabetes Injection Pens Price and Trend Forecast (2017-2022)
    11.2 EMEA Diabetes Injection Pens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Diabetes Injection Pens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Diabetes Injection Pens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Diabetes Injection Pens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Diabetes Injection Pens Sales Forecast by Type (2017-2022)
    11.7 EMEA Diabetes Injection Pens Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer